KIRKUS REVIEWS
SAYS "GET IT!"
"A thrilling synopsis of the current condition of the fight against cancer... A marvelous book that's packed with knowledge, insight, and hope" -
Kirkus Reviews
2024 GLOBAL BOOK AWARDS SILVER MEDAL WINNER!
"A" rating from
Booklife
by
Publisher's Weekly: "
Kelner proves a welcoming guide whose
optimism is infectious.
This book bursts with good news."
In
Taming Cancer
, a
biochemist and immunologist with 37 years of experience
in the biotechnology industry
developing innovative cancer medicines
provides an
insider's view
of how
immunotherapy
and other newly emerging therapeutics are
changing the lives of cancer patients
today by improving both the
quality and duration of their lives
and, for the most fortunate of patients, totally
eradicating their tumors
, thereby achieving the
"Holy Grail" of cancer medicine: the long-sought cure for cancer.
In an
engaging narrative covering two centuries of biological discovery
, Dr. Kelner describes how these
astonishing "living drugs
," which are comprised of
engineered viruses, cells, and proteins
(such as
monoclonal antibodies
),
target
the root causes of cancer
and
stimulate the immune system to seek out and destroy tumors.
sends a message of hope
to current and future cancer patients the world over by presenting
a
lucid vision
of a time
when a diagnosis of
metastatic cancer is no longer by default a harbinger of impending suffering and death
.
Expertly written
in
accessible language
for readers interested in developing a
conceptual understanding of cancer
what can be done to confront it
, the book also provides
extensive scientific commentary in the
endnotes
for biology students, medical and graduate students, physicians, nurses, allied health care professionals, scientists, and anyone else interested in
learning more
about the
fascinating and mysterious realm of the human cancer cell.
A
Reedsy Discovery
"Must Read"
"Kelner's...
writing shines in its ability to distill complex scientific concepts into accessible language
, making the content valuable for both laypersons and professionals."